Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · IEX Real-Time Price · USD
3.100
+0.070 (2.31%)
Mar 28, 2024, 3:59 PM EDT - Market closed

RANI Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019
Revenue
002.720.460.98
Revenue Growth (YoY)
--488.10%-52.81%-
Gross Profit
002.720.460.98
Selling, General & Admin
26.4826.8427.834.963.47
Research & Development
39.6236.6126.4812.0424.58
Operating Expenses
66.163.4554.3217.0128.04
Operating Income
-66.1-63.45-51.6-16.54-27.07
Interest Expense / Income
5.091.070.470.120.01
Other Expense / Income
-37.21-34-43.78--0.49
Pretax Income
-33.97-30.52-8.29-16.67-26.59
Income Tax
00.070.040.040
Net Income
-33.97-30.59-8.33-16.7-26.59
Shares Outstanding (Basic)
2624204747
Shares Outstanding (Diluted)
2624204747
Shares Change
7.09%21.93%-58.34%--
EPS (Basic)
-1.33-1.28-0.43-0.36-0.57
EPS (Diluted)
-1.33-1.28-0.43-0.36-0.57
Free Cash Flow
-52.47-48.13-32.75-16.16-27.8
Free Cash Flow Per Share
-2.06-2.02-1.68-0.34-0.59
Gross Margin
--100.00%100.00%100.00%
Operating Margin
---1899.12%-3580.95%-2764.56%
Profit Margin
---306.62%-3615.37%-2715.73%
Free Cash Flow Margin
---1205.41%-3497.84%-2839.53%
EBITDA
-27.02-28.14-7.33-15.96-26.01
EBITDA Margin
---269.67%-3453.46%-2657.10%
Depreciation & Amortization
1.861.310.50.590.56
EBIT
-28.89-29.45-7.82-16.54-26.58
EBIT Margin
---287.96%-3580.95%-2714.71%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).